BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 2785966)

  • 1. Role of local IgA antitoxin-producing cells for intestinal protection against cholera toxin challenge.
    Lycke N; Bromander AK; Holmgren J
    Int Arch Allergy Appl Immunol; 1989; 88(3):273-9. PubMed ID: 2785966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against cholera toxin after oral immunization is thymus-dependent and associated with intestinal production of neutralizing IgA antitoxin.
    Lycke N; Eriksen L; Holmgren J
    Scand J Immunol; 1987 Apr; 25(4):413-9. PubMed ID: 3576135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adoptive transfer of gut mucosal antitoxin memory by isolated B cells 1 year after oral immunization with cholera toxin.
    Lycke N; Holmgren J
    Infect Immun; 1989 Apr; 57(4):1137-41. PubMed ID: 2784416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sensitive method for the detection of specific antibody production in different isotypes from single lamina propria plasma cells.
    Lycke N
    Scand J Immunol; 1986 Oct; 24(4):393-403. PubMed ID: 3764344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term cholera antitoxin memory in the gut can be triggered to antibody formation associated with protection within hours of an oral challenge immunization.
    Lycke N; Holmgren J
    Scand J Immunol; 1987 Apr; 25(4):407-12. PubMed ID: 3576134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of J chain inhibits the transport of gut IgA and abrogates the development of intestinal antitoxic protection.
    Lycke N; Erlandsson L; Ekman L; Schön K; Leanderson T
    J Immunol; 1999 Jul; 163(2):913-9. PubMed ID: 10395687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgA isotype restriction in the mucosal but not in the extramucosal immune response after oral immunizations with cholera toxin or cholera B subunit.
    Lycke N; Lindholm L; Holmgren J
    Int Arch Allergy Appl Immunol; 1983; 72(2):119-27. PubMed ID: 6874106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host defense against cholera toxin is strongly CD4+ T cell dependent.
    Hörnqvist E; Goldschmidt TJ; Holmdahl R; Lycke N
    Infect Immun; 1991 Oct; 59(10):3630-8. PubMed ID: 1910010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral immunization with a free peptide from cholera toxin: local protection and IgA production.
    Pedoussaut S; Delmas A; Milhaud G; Rivaille P; Gruaz-Guyon A
    Mol Immunol; 1989 Feb; 26(2):115-9. PubMed ID: 2918857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant.
    Jackson RJ; Fujihashi K; Xu-Amano J; Kiyono H; Elson CO; McGhee JR
    Infect Immun; 1993 Oct; 61(10):4272-9. PubMed ID: 8406816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strong differential regulation of serum and mucosal IgA responses as revealed in CD28-deficient mice using cholera toxin adjuvant.
    Gärdby E; Wrammert J; Schön K; Ekman L; Leanderson T; Lycke N
    J Immunol; 2003 Jan; 170(1):55-63. PubMed ID: 12496383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local (immunoglobulin A) immune response by the intestine to cholera toxin and its partial suppression with combined systemic and intra-intestinal immunization.
    Yardley JH; Keren DF; Hamilton SR; Brown GD
    Infect Immun; 1978 Feb; 19(2):589-97. PubMed ID: 631891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-6-deficient mice exhibit normal mucosal IgA responses to local immunizations and Helicobacter felis infection.
    Bromander AK; Ekman L; Kopf M; Nedrud JG; Lycke NY
    J Immunol; 1996 Jun; 156(11):4290-7. PubMed ID: 8666800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-gamma receptor-deficient mice exhibit impaired gut mucosal immune responses but intact oral tolerance.
    Kjerrulf M; Grdic D; Ekman L; Schön K; Vajdy M; Lycke NY
    Immunology; 1997 Sep; 92(1):60-8. PubMed ID: 9370925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bone marrow as a site of antibody production after a mucosal immunization.
    Benedetti R; Massouh E; Fló J
    Immunol Lett; 1995 Dec; 48(2):109-15. PubMed ID: 8719108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of the murine gut mucosal IgA response to cholera toxin with oral cyclosporine.
    Kawabata TT; Lin WQ; Ladics GS
    Fundam Appl Toxicol; 1992 Nov; 19(4):575-83. PubMed ID: 1426716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of the localization, magnitude, and duration of a specific mucosal IgA plasma cell response in enterically immunized rats.
    Pierce NF; Cray WC
    J Immunol; 1982 Mar; 128(3):1311-5. PubMed ID: 6173431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin.
    Elson CO; Ealding W
    J Immunol; 1984 Jun; 132(6):2736-41. PubMed ID: 6233359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term antibodies after an oral immunization with cholera toxin are synthesized in the bone marrow and may play a role in the regulation of memory B-cell maintenance at systemic and mucosal sites.
    Benedetti R; Lev P; Massouh E; Fló J
    Res Immunol; 1998 Feb; 149(2):107-18. PubMed ID: 9628392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal mucosal memory and presence of memory cells in lamina propria and Peyer's patches in mice 2 years after oral immunization with cholera toxin.
    Lycke N; Holmgren J
    Scand J Immunol; 1986 May; 23(5):611-6. PubMed ID: 3704560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.